Back to search
FDAFDA · Food and drugs·Recall number Z-0492-2013

DataCara GM is an information management system that provides data management functionality for managing blood glucose testing data.

Published December 19, 2012 · Recall initiated: July 16, 2012

Summary

FDA records medical device Class II recall Z-0492-2013, published December 19, 2012 and initiated July 16, 2012. Recalling firm: Roche Molecular Systems, Inc.; Status: Terminated; Reported quantity: 479 units; Lot: Device-associated diagnostic software. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Roche Molecular Systems, Inc. has become aware of a device-associated diagnostic software issue.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Roche Molecular Systems, Inc.
Distributor
Nationwide Distribution
Lot
Device-associated diagnostic software
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was DataCara GM is an information management system that provides data management functionality for managing blood glucose testing data. recalled?

Yes. FDA published recall Z-0492-2013 on December 19, 2012. Reported hazard: Roche Molecular Systems, Inc. has become aware of a device-associated diagnostic software issue.

What should I do if I have this product?

Voluntary: Firm initiated · Letter